You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 5, 2025

Details for Patent: 7,994,185


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,994,185 protect, and when does it expire?

Patent 7,994,185 protects TAFINLAR and is included in two NDAs.

Protection for TAFINLAR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-nine patent family members in thirty-four countries.

Summary for Patent: 7,994,185
Title:Benzene sulfonamide thiazole and oxazole compounds
Abstract: The present invention provides thiazole sulfonamide and oxazole sulfonamide compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.
Inventor(s): Rheault; Tara Renae (Durham, NC)
Assignee: Glaxo Smith Kline LLC (Philadelphia, PA)
Application Number:12/434,963
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,994,185
Patent Claim Types:
see list of patent claims
Compound; Composition; Dosage form; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,994,185

Introduction

United States Patent 7,994,185, titled "Benzene sulfonamide thiazole and oxazole compounds," is a patent that delves into the preparation, composition, and applications of specific chemical compounds. To analyze the scope and claims of this patent, it is essential to understand the key components and the broader patent landscape.

Patent Overview

The patent in question, US 7,994,185, focuses on benzene sulfonamide thiazole and oxazole compounds. These compounds are often used in pharmaceutical and chemical research due to their potential therapeutic properties.

Claims: The Heart of the Patent

Claims are the most critical part of a patent as they define the invention and determine what is protected by the patent[2][3].

Types of Claims

  • Independent Claims: These are standalone claims that do not rely on other claims. They define the broadest scope of the invention.
  • Dependent Claims: These claims build upon independent claims and narrow down the scope by adding additional limitations.

Claim Drafting Considerations

For patents like US 7,994,185, three key considerations are crucial:

  • Non-obviousness: The invention must be significantly different from existing knowledge in the field.
  • Novelty: The invention must be new and not previously disclosed.
  • Scope: The claims must be clear and specific enough to define the boundaries of the invention[2].

Scope of the Patent

The scope of a patent is determined by the language used in the claims. Here are some metrics and considerations:

Independent Claim Length (ICL) and Independent Claim Count (ICC)

Research suggests that the scope of a patent can be measured by the length and number of independent claims. Narrower claims, as indicated by shorter independent claim lengths and fewer independent claims, are often associated with a higher probability of grant and a shorter examination process[3].

Claim Clarity and Validity

Clear and specific claims are essential for maintaining patent quality. Broad or unclear claims can lead to increased licensing and litigation costs, potentially diminishing innovation incentives[3].

Examination Process and Patent Quality

The examination process at the USPTO plays a significant role in shaping the scope of patent claims. Here are some key points:

Narrowing of Claims

During the examination process, the scope of patent claims tends to narrow. This is reflected in both the length and count of independent claims. Longer examination durations often result in more significant narrowing of claim scope[3].

Litigation and Post-Grant Reviews

Litigated patents, which are often more valuable, experience longer and more complex prosecutions at the PTO. This suggests that the USPTO may be doing a better job in evaluating patents that really matter[3].

Inventorship and Prior Art

The quality of a patent can also be assessed through inventorship and prior art citations.

Inventorship

While more inventors and higher inventor prestige may indicate higher patent quality, this metric can overlook inventions by previously unknown inventors who have invested substantial time and effort[2].

Prior Art Citations

The number of prior art citations can also be an indicator of patent quality. However, the relationship is not straightforward; fewer prior art citations do not necessarily mean the invention is more novel or valuable[2].

Economic and Legal Implications

Patents confer a temporary monopoly to the holder, which can have significant economic and legal implications.

Financial Incentives

The USPTO's financial incentives can influence the patent landscape. For instance, the fee structure can affect the number of claims and the scope of the patent[2].

Litigation Costs

Broad or unclear claims can lead to increased litigation costs, which can impede innovation by creating barriers to entry for other inventors and companies[3].

Case Study: US 7,994,185

While the specific details of US 7,994,185 are not extensively discussed in the sources, we can apply the general principles outlined above.

  • Claims Analysis: The patent would have undergone a rigorous examination process to ensure that its claims meet the statutory requirements of non-obviousness, novelty, and clarity.
  • Scope Determination: The scope would be defined by the independent and dependent claims, with narrower claims likely resulting from the examination process.
  • Inventorship and Prior Art: The patent's quality could be assessed by looking at the number of inventors and prior art citations, though these metrics have their limitations.

Key Takeaways

  • Claims are Central: The claims in a patent define the invention and its scope.
  • Scope Metrics: Independent claim length and count are useful metrics for measuring patent scope.
  • Examination Process: The USPTO's examination process tends to narrow the scope of patent claims.
  • Inventorship and Prior Art: These factors can provide insights into patent quality but have their limitations.
  • Economic Implications: Patents can confer significant economic advantages but also create barriers to innovation if not managed properly.

FAQs

Q: What are the key components of a patent claim? A: The key components include non-obviousness, novelty, and scope. Claims must be clear and specific enough to define the boundaries of the invention.

Q: How does the USPTO examination process affect patent claims? A: The examination process tends to narrow the scope of patent claims in terms of both claim length and claim count, especially over longer durations.

Q: What metrics can be used to measure patent scope? A: Independent claim length (ICL) and independent claim count (ICC) are simple yet effective metrics for measuring patent scope.

Q: Why are prior art citations important in patent evaluation? A: Prior art citations help determine the novelty and non-obviousness of the invention, though fewer citations do not necessarily mean the invention is more valuable.

Q: How do broad or unclear claims impact innovation? A: Broad or unclear claims can lead to increased licensing and litigation costs, potentially diminishing innovation incentives by creating barriers to entry for other inventors and companies.

Sources

  1. US7994185B2 - Benzene sulfonamide thiazole and oxazole compounds - Google Patents
  2. INVENTIONS AND PATENTS FOR TREATING THYROID DISEASE - Indiana University Maurer School of Law
  3. Patent Claims and Patent Scope - Hoover Institution
  4. Benzene sulfonamide thiazole and oxazole compounds - Google Patents
  5. Dabrafenib and a process for the preparation thereof - googleapis.com

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 7,994,185

Showing 1 to 3 of 3 entries

International Family Members for US Patent 7,994,185

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 071617 ⤷  Try for Free
Australia 2009244491 ⤷  Try for Free
Brazil PI0912541 ⤷  Try for Free
Canada 2723396 ⤷  Try for Free
Chile 2009001065 ⤷  Try for Free
China 102083312 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.